CuII (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease.
Southon A, Szostak K, Acevedo KM, Dent KA, Volitakis I, Belaidi AA, Barnham KJ, Crouch PJ, Ayton S, Donnelly PS, Bush AI.
Southon A, et al. Among authors: szostak k.
Br J Pharmacol. 2020 Feb;177(3):656-667. doi: 10.1111/bph.14881. Epub 2020 Jan 14.
Br J Pharmacol. 2020.
PMID: 31655003
Free PMC article.